Given the low bar of the ALS standard of care, I don't think BP would need a completion of phase 2 if the results coming out are strong. And if the preclinicals for AD etc come up trumps, well, things could possibly move our way real fast.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)